Aventis Pharms S.A. et al. v. Apotex Inc. et al.

(08-496-GMS) (D. Del.). Patent infringement action regarding Apotex’s ANDA for Sanofi-Aventis’ anti-cancer product TAXOTERE® (docetaxel). Two-week trial. Invalidated all claims and Sanofi’s patents ruled unenforceable.

View All Results
Every case is different and results depend on their specific circumstances. Prior results do not guarantee a similar outcome.